 |
인쇄하기
취소
|
Celltrion gets green light in EU for antibody drug
Celltrion’s antibody drug Remsima won a final approval from the European Commission, the European Union’s executive arm, the company said Wednesday in its regulatory filing.
Celltrion officials said the EC’s approval will pave the way for the local drugmaker to export Remsima in 31 countries in Europe.
The European marketing of Remsima will be mainly handled by Celltrion Healthcare, a mar...
Celltrion officials said the EC’s approval will pave the way for the local drugmaker to export Remsima in 31 countries in Europe.
The European marketing of Remsima will be mainly handled by Celltrion Healthcare, a mar...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.